Phase 2 Resectable Lung Non-Small Cell Carcinoma Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic Triple-Negative Breast Carcinoma+97 more
Mayo Clinic132 enrolled1 locationNCT05269381
Recruiting
Phase 2
Proton Beam Radiation Therapy After Treatment for Resected N2 Non-Small Cell Lung Cancer
Resectable Lung Non-Small Cell Carcinoma
Emory University20 enrolled1 locationNCT06008730
Recruiting
Phase 2
A Study of Adebrelimab in Combination with Chemo with or Without Bevacizumab Neoadjuvant Therapy for Resectable NSCLC
Resectable Lung Non-Small Cell Carcinoma
The First Affiliated Hospital of Guangzhou Medical University60 enrolled1 locationNCT06775275
Recruiting
Phase 2
Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC
Neoadjuvant TherapyResectable Lung Non-Small Cell CarcinomaImmunotherapy+1 more
Shandong Cancer Hospital and Institute30 enrolled1 locationNCT06241807
Recruiting
Phase 2
A Phase II Trial to Evaluate the Efficiency and Safety of Serplulimab Plus Chemotherapy as Conversion Therapy in NSCLC
Unresectable Lung Non-Small Cell Carcinoma
Zhejiang University49 enrolled1 locationNCT05837052